ID27133A - Derivat-derivat asam sulfonilaminofin dan fosfonat - Google Patents

Derivat-derivat asam sulfonilaminofin dan fosfonat

Info

Publication number
ID27133A
ID27133A IDW20010108A ID20010108A ID27133A ID 27133 A ID27133 A ID 27133A ID W20010108 A IDW20010108 A ID W20010108A ID 20010108 A ID20010108 A ID 20010108A ID 27133 A ID27133 A ID 27133A
Authority
ID
Indonesia
Prior art keywords
acid
sulfonylaminofine
phosphoneate
derivates
acid derivates
Prior art date
Application number
IDW20010108A
Other languages
English (en)
Indonesian (id)
Inventor
Manfred Dr Schudok
Wilfried Dr Schwab
Gerhard Dr Zoller
Eckart Dr Bartnik
Frank Dr Buttner
Klaus Ulrich Dr Weithmann
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19831980A external-priority patent/DE19831980A1/de
Priority claimed from DE19921680A external-priority patent/DE19921680A1/de
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of ID27133A publication Critical patent/ID27133A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW20010108A 1998-07-16 1999-07-07 Derivat-derivat asam sulfonilaminofin dan fosfonat ID27133A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19831980A DE19831980A1 (de) 1998-07-16 1998-07-16 Sulfonylaminophosphin- und phosphonsäurederivate
DE19921680A DE19921680A1 (de) 1999-05-12 1999-05-12 Sulfonylaminophosphin- und phosphonsäurederivate

Publications (1)

Publication Number Publication Date
ID27133A true ID27133A (id) 2001-03-01

Family

ID=26047473

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010108A ID27133A (id) 1998-07-16 1999-07-07 Derivat-derivat asam sulfonilaminofin dan fosfonat

Country Status (22)

Country Link
US (2) US6235727B1 (zh)
EP (1) EP1097159B1 (zh)
JP (1) JP4567886B2 (zh)
KR (1) KR100615345B1 (zh)
CN (1) CN1194978C (zh)
AR (1) AR019390A1 (zh)
AT (1) ATE227295T1 (zh)
AU (1) AU754050B2 (zh)
BR (1) BR9912085A (zh)
CA (1) CA2337828C (zh)
CZ (1) CZ300780B6 (zh)
DE (1) DE59903329D1 (zh)
DK (1) DK1097159T3 (zh)
ES (1) ES2187171T3 (zh)
HK (1) HK1038363A1 (zh)
HU (1) HUP0102837A3 (zh)
ID (1) ID27133A (zh)
PL (1) PL199234B1 (zh)
PT (1) PT1097159E (zh)
RU (1) RU2224762C2 (zh)
TR (1) TR200100084T2 (zh)
WO (1) WO2000004030A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU770599B2 (en) 1999-07-06 2004-02-26 Methylgene Inc. Sulfonamidomethyl phosphonate inhibitors of beta-lactamase
MXPA05001544A (es) * 2002-08-08 2005-04-19 Smithkline Beecham Corp Compuestos de tiofeno.
JP4450192B2 (ja) 2004-07-01 2010-04-14 信越化学工業株式会社 珪素複合体及びその製造方法並びに非水電解質二次電池用負極材
US20100317625A1 (en) * 2006-05-22 2010-12-16 Dininno Frank Novel sulfonamidomethylphosphonate inhibitors of beta-lactamase
JP5562634B2 (ja) * 2006-05-22 2014-07-30 メチルジーン インコーポレイテッド ベータ−ラクタマーゼの新規阻害剤
JP5399219B2 (ja) * 2009-11-24 2014-01-29 株式会社ケイティーバイオ 関節リウマチに対するヒト型抗ＴＮＦα抗体薬の薬効予測方法、及び薬効予測装置
CN108676031A (zh) * 2018-05-29 2018-10-19 重庆威鹏药业有限公司 水溶性三唑类抗真菌膦酸化合物及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996040A (en) * 1974-06-28 1976-12-07 Monsanto Company Increasing sucrose content of sugar cane employing N-phenylsulfonamido-N-phosphonomethyl glycine and certain derivatives thereof
JPS6137800A (ja) * 1984-07-31 1986-02-22 Kyowa Hakko Kogyo Co Ltd 含リンペプチド
DE3435156A1 (de) * 1984-09-25 1986-04-03 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung der stereoisomeren von 1-amino-alkylphosphonsaeuren oder 1-aminoalkylphosphinsaeuren
JPS62148493A (ja) * 1985-12-24 1987-07-02 Teijin Ltd 新規ホスホン酸誘導体および除草剤
DE3770982D1 (de) * 1986-04-24 1991-08-01 Fujisawa Pharmaceutical Co Diphosphonsaeure-verbindungen, verfahren zu deren herstellung und sie enthaltende arzneimittel.
JP2764262B2 (ja) 1987-08-28 1998-06-11 持田製薬株式会社 ヒダントイン誘導体及びそれを有効成分とする医薬組成物
TW201303B (zh) 1990-07-05 1993-03-01 Hoffmann La Roche
JP2525977B2 (ja) * 1991-10-17 1996-08-21 昭和電工株式会社 Ｎ−アシルアミノメチルホスホン酸の製造法
US5455258A (en) 1993-01-06 1995-10-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
ATE191468T1 (de) 1994-06-22 2000-04-15 British Biotech Pharm Metalloproteinase inhibitoren
US5863949A (en) 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
KR980009238A (ko) * 1995-07-28 1998-04-30 우에노 도시오 설포닐아미노산 유도체
IL126832A0 (en) * 1996-05-17 1999-08-17 Warner Lambert Co Biphenylsulfonamide matrix metalloproteinase inhibitors
JP2001509795A (ja) * 1997-01-27 2001-07-24 ニィコメド・オーストリア・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 血液調節作用を有する新規化合物
DE59802394D1 (de) * 1997-05-09 2002-01-24 Hoechst Ag Substituierte Diaminocarbonsäuren
WO1998050348A1 (en) * 1997-05-09 1998-11-12 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
DE19719621A1 (de) * 1997-05-09 1998-11-12 Hoechst Ag Sulfonylaminocarbonsäuren

Also Published As

Publication number Publication date
KR100615345B1 (ko) 2006-08-25
CN1309660A (zh) 2001-08-22
JP2002520418A (ja) 2002-07-09
EP1097159A1 (de) 2001-05-09
PL345653A1 (en) 2002-01-02
AU754050B2 (en) 2002-10-31
PL199234B1 (pl) 2008-08-29
US6500811B2 (en) 2002-12-31
HK1038363A1 (en) 2002-03-15
HUP0102837A2 (hu) 2001-12-28
CN1194978C (zh) 2005-03-30
JP4567886B2 (ja) 2010-10-20
US6235727B1 (en) 2001-05-22
CZ2001144A3 (en) 2001-05-16
EP1097159B1 (de) 2002-11-06
DK1097159T3 (da) 2003-03-10
ATE227295T1 (de) 2002-11-15
CZ300780B6 (cs) 2009-08-12
TR200100084T2 (tr) 2001-07-23
RU2224762C2 (ru) 2004-02-27
PT1097159E (pt) 2003-03-31
BR9912085A (pt) 2001-04-10
WO2000004030A1 (de) 2000-01-27
ES2187171T3 (es) 2003-05-16
DE59903329D1 (en) 2002-12-12
CA2337828C (en) 2010-08-17
CA2337828A1 (en) 2000-01-27
AR019390A1 (es) 2002-02-20
AU4908299A (en) 2000-02-07
US20020082246A1 (en) 2002-06-27
HUP0102837A3 (en) 2002-04-29
KR20010071940A (ko) 2001-07-31

Similar Documents

Publication Publication Date Title
ID23953A (id) Asam 5-alkil-2-arilaminofenilasetat dan turunannya
ID26222A (id) Hidroksamida asam(4-arilsulfonilamino)-tetrahidropiran-4-karboksilat
ID20807A (id) Asam sulfonilaminokarboksilat
ID21201A (id) Metode dan peralatan untuk pembuatan asam terephtalat murni
ID30181A (id) Asam antranilat- dan asam tioantranilat-n-aril amida
ID20809A (id) Asam diaminokarboksilat tersubstitusi
ID29591A (id) Senyawa-senyawa kuinolina dan kuinoksalina
ID23575A (id) Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
ID18421A (id) Pembuatan asam akrilat dan asam metakrilat
ID28699A (id) Turunan-turunan asam oksiiminoalkanoat
ID22095A (id) Asam aril-akrilat ester
DE19981672D2 (de) Antriebsstrang
ID22957A (id) Senyawa dan penggunaannya
ID21361A (id) Baterai dan metode pembuatannya
DK1100769T3 (da) Aminomethylcarboxylsyrederivater
ID28482A (id) Derivat-derivat kromenon dan kromanon sebagai penghambat-penghambat integrin
PT878467E (pt) Acidos 6-aminotetra-hidroisoquinolinacarboxilicos e 7-aminotetra-hidroisoquinolinacarboxilicos substituidos
ID18425A (id) Pembuatan asam akrilat dan asam metakrilat
ID23258A (id) Penarik pemberian-menyilang dan metodenya
ID25983A (id) Asam aril karboksilat dan turunan-turunan tetrazola
ID22688A (id) Polimerisasi yang dikatalisa oleh asam dan diperbaiki
ID27133A (id) Derivat-derivat asam sulfonilaminofin dan fosfonat
ID24807A (id) Proses untuk mendapatkan asam l-dihidroorotat dan penggunaanya
ID21355A (id) Pembuatan asam adipat
ID22212A (id) Turunan-turunan asam hidroksamat